Finally, using a connectivity map (CMap) and molecular docking analyses, we identified three potential small molecules targeting CEP55, which may mitigate the immunosuppressive microenvironment and enhance the anti-tumor effect of ICIs. The gene discussed is CEP55; the disease is neoplasm.